116 related articles for article (PubMed ID: 37800780)
21. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
[TBL] [Abstract][Full Text] [Related]
22. Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysis.
Wu D; Yang Y; Jiang M; Yao R
BMC Urol; 2022 Mar; 22(1):42. PubMed ID: 35331219
[TBL] [Abstract][Full Text] [Related]
23. Trends in suicide mortality among cancer survivors in the US, 1975-2020.
Wan H; Chen R; Zhan X; Chen L; Li Z
Aging (Albany NY); 2024 Jan; 16(2):1685-1695. PubMed ID: 38261745
[TBL] [Abstract][Full Text] [Related]
24. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
25. Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis.
Yang H; Mei T
Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35512177
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
27. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
28. Deaths from COPD in patients with cancer: a population-based study.
Zheng Y; Huang Y; Zheng X; Peng J; Chen Y; Yu K; Yang Y; Wang X; Yang X; Qian J; Wang X; Gao X; Wu B
Aging (Albany NY); 2021 Apr; 13(9):12641-12659. PubMed ID: 33910167
[TBL] [Abstract][Full Text] [Related]
29. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis.
Mo X; Zhou M; Yan H; Chen X; Wang Y
BMC Cancer; 2021 Jan; 21(1):13. PubMed ID: 33402111
[TBL] [Abstract][Full Text] [Related]
30. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
[TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
32. Chronic Obstructive Pulmonary Disease Mortality in Bladder Cancer Patients: A SEER-Based Competing Risk Analysis.
Wang S; Ge C
Urol J; 2024 May; 21(3):146-154. PubMed ID: 37727915
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Prognostic Significance of TNM Staging Guidelines in Lung Carcinoid Tumors.
Yoon JY; Sigel K; Martin J; Jordan R; Beasley MB; Smith C; Kaufman A; Wisnivesky J; Kim MK
J Thorac Oncol; 2019 Feb; 14(2):184-192. PubMed ID: 30414942
[TBL] [Abstract][Full Text] [Related]
34. Marital status independently predicts testis cancer survival--an analysis of the SEER database.
Abern MR; Dude AM; Coogan CL
Urol Oncol; 2012; 30(4):487-93. PubMed ID: 20870430
[TBL] [Abstract][Full Text] [Related]
35. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
Lin SH; Zhang N; Godby J; Wang J; Marsh GD; Liao Z; Komaki R; Ho L; Hofstetter WL; Swisher SG; Mehran RJ; Buchholz TA; Elting LS; Giordano SH
Cancer; 2016 Mar; 122(6):917-28. PubMed ID: 26716915
[TBL] [Abstract][Full Text] [Related]
36. A Competing Risk Model Nomogram to Predict the Long-Term Prognosis of Lung Carcinoid.
Wang T; Zhou J; Zheng Q; Wu D; Lu T; Lin M; Pu Q; Mei J; Liu L
Ann Surg Oncol; 2023 Sep; 30(9):5830-5839. PubMed ID: 36917336
[TBL] [Abstract][Full Text] [Related]
37. Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: A competing risk analysis.
Zhong J; Zheng Q; An T; Zhao J; Wu M; Wang Y; Zhuo M; Li J; Zhao X; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
Thorac Cancer; 2019 Sep; 10(9):1788-1797. PubMed ID: 31318178
[TBL] [Abstract][Full Text] [Related]
38. Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.
Steuer CE; Behera M; Kim S; Chen Z; Saba NF; Pillai RN; Owonikoko TK; Khuri FR; Ramalingam SS
J Thorac Oncol; 2015 Mar; 10(3):479-85. PubMed ID: 25371080
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531).
Mocellin S; Nitti D
Ann Oncol; 2013 Dec; 24(12):3040-4. PubMed ID: 24050954
[TBL] [Abstract][Full Text] [Related]
40. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
